Anillin, Actin Binding Protein (ANLN) (N-Term) Peptide
Quick Overview for Anillin, Actin Binding Protein (ANLN) (N-Term) Peptide (ABIN8094623)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- ANLN Peptide - N-terminal region
-
Sequence
- EHGKGSLEEA EAERLLLIAT GKRTLLIDEL NKLKNEGPQR KNKASPQSEF
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti- ANLN Antibody (ARP79372_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- Anillin (ANLN) (Anillin, Actin Binding Protein (ANLN))
-
Background
-
Background Information: This gene encodes an actin-binding protein that plays a role in cell growth and migration, and in cytokinesis. The encoded protein is thought to regulate actin cytoskeletal dynamics in podocytes, components of the glomerulus. Mutations in this gene are associated with focal segmental glomerulosclerosis 8. Alternative splicing results in multiple transcript variants encoding different isoforms.
Alternative Symbols: scra, FSGS8, Scraps
-
Molecular Weight
- 123 kDa
-
Gene ID
- 54443
-
NCBI Accession
- NP_001271230
-
UniProt
- Q9NQW6
Target
-
